TIAN Hengli
TIAN Hengli
Clinical Professor
Email: tianhlsh@126.com
Tel: 021-
Research Interests: Basic and clinical research of traumatic brain injury,
cerebrovascular disease Accident and neurocritical care
Biography
TIAN Hengli, Director of Neurosurgery, Clinical Professor, Doctoral Supervisor, Shanghai Leading Talent. Committee Member of the Neurosurgery Branch of Chinese Medical Association, Committee Member of Traumatology Branch of the Chinese Medical Association, Committee Member of World Federation of Neurosurgical Societies, Standing Committee Member of Neural Injury Training Committee of Chinese Medical Doctor Association, Vice President of Neurosurgeon Branch of Shanghai Medical Doctor Association, Vice Chairman of Trauma Branch of Shanghai Medical Association, etc. Clinical specialty areas: traumatic brain injury, cerebrovascular disease, neurocritical care, brain and spinal cord tumors, and intervertebral disc disease. Professor Tian has always engaged in the clinical treatment of neurosurgical diseases, especially severe traumatic brain injury and intracerebral hemorrhage.
Publications
Gong QY, Cai L, Jing Y, Wang W, Yang DX, Chen SW, Tian HL. Urolithin A alleviates blood-brain barrier disruption and attenuates neuronal apoptosis following traumatic brain injury in mice. Neural Regen Res. 2022, 17(9):2007-2013.
Cai L, Gong Q, Qi L, Xu T, Suo Q, Li X, Wang W, Jing Y, Yang D, Xu Z, Yuan F, Tang Y, Yang G, Ding J, Chen H, Tian H. ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT/NFκB/NLRP3 pathway. Cell Commun Signal, 2022, 20:56.
Yang DX, Jing Y, Liu YL, Xu ZM, Yuan F, Wang ML, Geng Z, Tian HL. Inhibition of Transient Receptor Potential Vanilloid 1 Attenuates Blood-Brain Barrier Disruption after Traumatic Brain Injury in Mice. J Neurotrauma, 2019, 36:1279-1290.
Comparative atlas of traumatic brain injury. Beijing: Wang TH, Tian HL, Zhao N, 2018: 1-154.
Liu YL, Yuan F, Yang DX, Xu ZM, Jing Y, Yang GY, Geng Z, Xia WL, Tian HL. Adjudin Attenuates Cerebral Edema and Improves Neurological Function in Mice with Experimental Traumatic Brain Injury. J Neurotrauma, 2018, 35:2850-2860.
Xu ZM, Yuan F, Liu YL, Ding J, Tian HL. Glibenclamide Attenuates Blood-Brain Barrier Disruption in Adult Mice after Traumatic Brain Injury. J Neurotrauma, 2017, 34(4):925-933.
Yuan F, Xu ZM, Lu LY, Nie H, Ding J, Ying WH, Tian HL. SIRT2 inhibition exacerbates neuroinflammation and blood-brain barrier disruption in experimental traumatic brain injury by enhancing NF-κB p65 acetylation and activation. J Neurochem, 2016, 136(3):581-93.
Yuan F, Ding J, Chen H, Guo Y, Wang G, Gao WW, Chen SW, Tian HL. Predicting progressive hemorrhagic injury after traumatic brain injury: derivation and validation of a risk score based on admission characteristics. J Neurotrauma, 2012, 29(12):2137-42.
Yuan F, Ding J, Chen H, Guo Y, Wang G, Gao WW, Chen SW, Tian HL. Predicting outcomes after traumatic brain injury: the development and validation of prognostic models based on admission characteristics. J Trauma Acute Care Surg, 2012, 73(1):137-45.
Tian HL, Guo Y, Hu J, Rong BY, Wang G, Gao WW, Chen SW, Chen H. Clinical characterization of comatose patients with cervical spine injury and traumatic brain injury. J Trauma, 2009, 67(6):1305-1310.